We hypothesize that the 24 h 3‐MA pretreatment may disrupt the positive feedback loop between CAFs and tumour cells by acutely interrupting SRGN secretion, leading to a sustained transition of CAFs to a low‐activity state. The gene discussed is SRGN; the disease is neoplasm.